Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia

International Archives of Allergy and Immunology

Volumn 142, Issue 4, 2007, Pages 285-290

  Matsuno, Osamu ^a   Miyazaki, Eishi ^a   Nureki, Shinichi ^a   Ueno, Takuya ^a   Ando, Masaru ^a   Ito, Kazunobu ^a   Kumamoto, Toshihide ^a   Higuchi, Yasunori ^b  

^a OITA UNIVERSITY   (Japan)

^b Shinbeppu Hospital   (Japan)

Author keywords

ADAM8; CD23; Eosinophilic pneumonia; VCAM 1

Indexed keywords

ADAM PROTEIN; CD23 ANTIGEN; IMMUNOGLOBULIN E RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; LOEFFLER PNEUMONIA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOKING;

ADAM PROTEINS; ADOLESCENT; ADULT; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PULMONARY EOSINOPHILIA; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33947197430     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097359     Document Type: Article

References (27)

1. Hayakawa H, Sato A, Toyoshima M, et al: A clinical study of idiopathic eosinophilic pneumonia. Chest 1994;105:1462-1466.
2. Fujimura M, Yasui M, Shinagawa S, et al: Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Respir Med 1998;92:743-749.
3. Nakahara Y, Hayashi S, Fukuno Y, et al: Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia. Respiration 2001;68:389-395.
4. Mochimaru H, Kawamoto M, Fukuda Y, et al: Clinicopathological differences between acute and chronic eosinophilic pneumonia. Respirology 2005;10:76-85.
5. Johansson MW, Lye MH, Barthel SR, et al: Eosinophils adhere to vascular cell adhesion molecule-1 via podosomes. Am J Respir Cell Mol Biol 2004;31:413-422.
6. Fourie AM, Coles F, Moreno V, et al: Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem 2003;278:30469-30477.
7. Hakansson L, Bjornsson E, Janson C, et al: Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma. J Allergy Clin Immunol 1995;96:941-950.
8. Chin JE, Hatfield CA, Winterrowd GE, et al: Airway recruitment of leukocytes in mice is dependent on alpha4-integrins and vascular cell adhesion molecule-1. Am J Physiol 1997; 272:L219-L229.
9. Cernadas M, De Sanctis GT, Krinzman SJ, et al: CD23 and allergic pulmonary inflammation: potential role as an inhibitor. Am J Respir Cell Mol Biol 1999;20:1-8.
10. Riffo-Vasquez Y, Spina D, Thomas M, et al: The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice. Clin Exp Allergy 2000;30:728-738.
11. King NE, Zimmermann N, Pope SM, et al: Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am J Respir Cell Mol Biol 2004;31:257-265.
12. Matsuno O, Miyazaki E, Nureki S, et al: Role of ADAM8 in experimental asthma. Immunol Lett 2006;102:67-73.
13. Allen JN, Pacht ER, Gadek JE, et al: Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-574.
14. Carrington CB, Addington WW, Goff AM, et al: Chronic eosinophilic pneumonia. N Engl J Med 1969;280:787-798.
15. Crystal RG, Bitterman PB, Rennard SI, et al: Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:154-166.
16. Van Eerdewegh P, Little RD, Dupuis J, et al: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-430.
17. Lee YW, Kuhn H, Hennig B, et al: IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 2001;33:83-94.
18. Gosset P, Tillie-Leblond I, Janin A, et al: Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and nonallergic asthmatic patients. Int Arch Allergy Immunol 1995;106:69-77.
19. Rose DM, Han J, Ginsberg MH: Alpha4 integrins and the immune response. Immunol Rev 2002;186:118-124.
20. Zangrilli JG, Shaver JR, Cirelli RA, et al: sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 1995;151:1346-1353.
21. Garton KJ, Gough PJ, Philalay J, et al: Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 2003;278:37459-37464.
22. Yu P, Kosco-Vilbois M, Richards M, et al: Negative feedback regulation of IgE synthesis by murine CD23. Nature 1994;369:753-756.
23. Fujiwara H, Kikutani H, Suematsu S, et al: The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 1994; 91:6835-6839.
24. Stief A, Texido G, Sansig G, et al: Links mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J Immunol 1994;152:3378-3390.
25. Texido G, Eibel H, Le Gros G, et al: Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J Immunol 1994;153:3028-3042.
26. Schlomann U, Wildeboer D, Webster A, et al: The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem 2002;277:48210-48219.
27. Schluesener HJ: The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccine. J Neuroimmunol 1998;87:197-202.